[New developments in the treatment of cancer].
Salamanca-Gómez
F
F
Unidad de Investigación Médica en Genética Humana, Centro Médico Nacional Siglo XXI IMSS, México, D.F.
D000818:Animals; D002869:Chromosome Aberrations; D016207:Cytokines / Q000627:therapeutic use; D003603:Cytotoxins / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000235:genetics; D005260:Female; D005966:Glucuronidase; D006026:Glycoside Hydrolases / Q000037:antagonists & inhibitors / Q000235:genetics; D016233:Immunotherapy, Active; D000922:Immunotoxins / Q000627:therapeutic use; D008297:Male; D051379:Mice; D008819:Mice, Nude; D009362:Neoplasm Metastasis / Q000235:genetics / Q000517:prevention & control / Q000628:therapy; D009369:Neoplasms / Q000235:genetics / Q000378:metabolism / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000628:therapy; D009389:Neovascularization, Pathologic / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics; D009857:Oncogenes / Q000235:genetics; D010770:Phosphotransferases / Q000378:metabolism; D012334:RNA, Neoplasm / Q000235:genetics; D051381:Rats; D012106:Research; D012514:Sarcoma, Kaposi / Q000628:therapy; D000099175:Heparanase
D016207:Cytokines; D003603:Cytotoxins; D004273:DNA, Neoplasm; D005966:Glucuronidase; D006026:Glycoside Hydrolases; D000922:Immunotoxins; D010770:Phosphotransferases; D012334:RNA, Neoplasm; D000099175:Heparanase